• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多价疫苗:前景与挑战。

Multivalent vaccines: prospects and challenges.

作者信息

Spier R E

机构信息

University of Surrey, Guildford, UK.

出版信息

Folia Microbiol (Praha). 1997;42(2):105-12. doi: 10.1007/BF02898716.

DOI:10.1007/BF02898716
PMID:9306653
Abstract

The advantages and disadvantages of combination vaccines are set out with a clear indication that, although there are many (described and discussed) influences on in the immunogenicity of a vaccine it would still be of considerable value to be able to deliver such materials with the minimum number of needle-stick injections. Such a situation may become facilitated in the future as vaccines based on plasmid DNA become available; a prospect which is examined in outline in the final section.

摘要

文中阐述了联合疫苗的优缺点,并明确指出,尽管疫苗的免疫原性受到多种(已描述和讨论过的)因素影响,但能够以最少的注射次数接种此类疫苗仍具有相当大的价值。随着基于质粒DNA的疫苗问世,这种情况在未来可能会变得更加容易实现;最后一部分将简要探讨这一前景。

相似文献

1
Multivalent vaccines: prospects and challenges.多价疫苗:前景与挑战。
Folia Microbiol (Praha). 1997;42(2):105-12. doi: 10.1007/BF02898716.
2
HIV vaccine developers battle on, despite high-profile failures.尽管遭遇重大失败,HIV疫苗开发者仍在继续努力。
Nat Biotechnol. 2008 Jun;26(6):591-2. doi: 10.1038/nbt0608-591.
3
Multivalent DNA Vaccines as A Strategy to Combat Multiple Concurrent Epidemics: Mosquito-Borne and Hemorrhagic Fever Viruses.多价 DNA 疫苗作为应对多种并发传染病的策略:蚊媒和出血热病毒。
Viruses. 2021 Feb 27;13(3):382. doi: 10.3390/v13030382.
4
Combination vaccines.联合疫苗
Int J Technol Assess Health Care. 1994 Winter;10(1):185-92. doi: 10.1017/s0266462300014112.
5
Prospects for an HIV vaccine: conventional approaches and DNA immunization.HIV疫苗的前景:传统方法与DNA免疫
Biotechnol Genet Eng Rev. 2002;19:205-42. doi: 10.1080/02648725.2002.10648030.
6
Upstream processing of plasmid DNA for vaccine and gene therapy applications.用于疫苗和基因治疗应用的质粒DNA上游加工。
Recent Pat Biotechnol. 2008;2(3):156-72. doi: 10.2174/187220808786241015.
7
Combination vaccines.联合疫苗
Prim Care. 2001 Dec;28(4):739-61, vi. doi: 10.1016/s0095-4543(05)70039-7.
8
Immunogenicity of DNA vaccines in humans: it takes two to tango.DNA疫苗在人体中的免疫原性:双人舞需要两人配合。
Hum Vaccin. 2008 Nov-Dec;4(6):449-52. doi: 10.4161/hv.4.6.6179. Epub 2008 Nov 28.
9
6th Annual Vaccines: all things considered.第六届年度疫苗大会:综合考量所有因素。
Expert Rev Vaccines. 2009 Mar;8(3):281-4. doi: 10.1586/14760584.8.3.281.
10
Methods to improve the immunogenicity of plasmid DNA vaccines.提高质粒DNA疫苗免疫原性的方法。
Drug Discov Today. 2021 Nov;26(11):2575-2592. doi: 10.1016/j.drudis.2021.06.008. Epub 2021 Jun 30.

引用本文的文献

1
Exosome-Based Multivalent Vaccine: Achieving Potent Immunization, Broadened Reactivity, and Strong T-Cell Responses with Nanograms of Proteins.基于外泌体的多价疫苗:用纳克级蛋白质实现有效的免疫接种、广泛的反应性和强烈的 T 细胞反应。
Microbiol Spectr. 2023 Jun 15;11(3):e0050323. doi: 10.1128/spectrum.00503-23. Epub 2023 Apr 24.
2
Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV.含 H5N1/EV71/JEV 亚微米颗粒和灭活病毒的三价疫苗的制备及免疫评价。
Hum Vaccin Immunother. 2013 Nov;9(11):2378-85. doi: 10.4161/hv.25639. Epub 2013 Jul 9.
3

本文引用的文献

1
Report of a meeting on "Vaccines; new technologies and applications".关于“疫苗;新技术与应用”会议的报告
Vaccine. 1995 Aug;13(11):1038-9. doi: 10.1016/0264-410x(95)90155-i.
2
Immune responses to pertussis vaccines concurrently administered with viral vaccines.对与病毒疫苗同时接种的百日咳疫苗的免疫反应。
Ann N Y Acad Sci. 1995 May 31;754:89-96. doi: 10.1111/j.1749-6632.1995.tb44441.x.
3
A perspective on issues relating to future vaccines.对未来疫苗相关问题的一种观点。
Multivalent fusion protein vaccine for lymphatic filariasis.
多价融合蛋白疫苗治疗淋巴丝虫病。
Vaccine. 2013 Mar 15;31(12):1616-22. doi: 10.1016/j.vaccine.2012.09.055. Epub 2012 Oct 2.
Ann N Y Acad Sci. 1995 May 31;754:388-95. doi: 10.1111/j.1749-6632.1995.tb44475.x.
4
Utility of large-linked databases in vaccine safety, particularly in distinguishing independent and synergistic effects. The Vaccine Safety Datalink Investigators.大型关联数据库在疫苗安全性方面的效用,尤其是在区分独立效应和协同效应方面。疫苗安全数据链研究人员。
Ann N Y Acad Sci. 1995 May 31;754:377-82. doi: 10.1111/j.1749-6632.1995.tb44473.x.
5
Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccination.关于预测保护性疫苗效力定义替代血清学检测:脊髓灰质炎病毒疫苗接种
Ann N Y Acad Sci. 1995 May 31;754:289-99. doi: 10.1111/j.1749-6632.1995.tb44462.x.
6
Combination vaccines: regulatory issues.联合疫苗:监管问题。
Ann N Y Acad Sci. 1995 May 31;754:27-34. doi: 10.1111/j.1749-6632.1995.tb44435.x.
7
Practical considerations regarding the impact on immunization schedules of the introduction of new combined vaccines.关于引入新的联合疫苗对免疫接种计划影响的实际考量。
Ann N Y Acad Sci. 1995 May 31;754:250-4. doi: 10.1111/j.1749-6632.1995.tb44457.x.
8
Combination vaccines for diphtheria, tetanus, pertussis, and Haemophilus influenzae type b.
Ann N Y Acad Sci. 1995 May 31;754:108-13. doi: 10.1111/j.1749-6632.1995.tb44443.x.
9
Combined Vaccines and Simultaneous Administration: Current Issues and Perspectives. Conference proceedings. Bethesda, Maryland, July 28-30, 1993.联合疫苗与同时接种:当前问题与展望。会议论文集。马里兰州贝塞斯达,1993年7月28 - 30日。
Ann N Y Acad Sci. 1995 May 31;754:xi-xv, 1-404.
10
Protection of cattle against foot-and-mouth disease by a synthetic peptide.一种合成肽对牛口蹄疫的防护作用。
Science. 1986 May 2;232(4750):639-41. doi: 10.1126/science.3008333.